Counselors in Waupun, WI Accepting Medicare

5 Counselors found. Showing 1 - 5

Kourtney Kaye Lechner Ullrich, MS LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 620 W Brown St, Waupun, WI 53963 Phone: 920-926-4200

Kamelah Reed Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 200 S Madison St, Waupun, WI 53963 Phone: 414-301-1741

Hannah Domasky, LPC-IT Counselor - Professional Medicare: Medicare Enrolled Practice Location: 620 W Brown St, Waupun, WI 53963 Phone: 920-324-5581

Alyssa A Hallgren, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 620 W Brown St, Waupun, WI 53963 Phone: 920-926-4200

Panou Lee Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 620 W Brown St, Waupun, WI 53963 Phone: 920-324-7600

News Archive

Study examines link between gestational age at birth and mortality in young adulthood

In a study that included more than 600,000 individuals born in Sweden between 1973-1979, those born preterm had a higher risk of death during early childhood and young adulthood than persons born at term, according to a study in the September 21 issue of JAMA.

NHS whistle blowers need more protection

A consultant pediatrician who had come forth with concerns about a clinic where Baby Peter was treated days before his death has accused NHS managers of using employment laws to gag potential whistleblowers.

Could an antiviral mouthwash using silver nanoparticles prevent COVID-19?

In a recent study by researchers in Mexico, Russia and Spain, silver nanoparticles (AgNPs) were found to inhibit SARS-CoV-2 in healthcare workers. They propose a non-pharmaceutical public health intervention consisting of mouthwash and nose rinse with an AgNPs solution to reduce morbidity among healthcare personnel exposed to the SARS-CoV-2 virus.

Extension study data on Fampridine-SR drug

Data from two long-term open-label extension studies of Fampridine-SR show that 86.0% of participants remained on therapy after a maximum treatment time of 15 months in study MS-F204EXT, and 69.5% remained on therapy after a maximum treatment time of 36 months in study MS-F203EXT.

RainDance Technologies enters into strategic agreement with Applied Biosystems

RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.

Read more Medical News

› Verified 3 days ago